Aron Shapiro
Seminars
Wednesday 19th November 2025
Veradermics Pattern Hairloss Studies: Efficacy Endpoints with Validated Imaging Tools
1:30 pm
- Founded by practicing dermatologists, ensuring clinical relevance and patient-centered innovation
- VDPHL: A novel, non-hormonal oral investigational drug targeting androgenetic alopecia (AGA) that could offer a differentiated safety and efficacy profile
- High quality, standardized, reproducible imaging builds confidence for quality oversight and quantitative measurements for regulatory endpoints submission
